IVF (INVO Fertility) Risk Assessment


IVF INVO Fertility Inc IVF
35 GF Score
Price $1.13
GF Value $134.71
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is INVO Fertility Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of INVO Fertility is: No Data: Cannot be evaluated.

INVO Fertility  (NAS:IVF) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

INVO Fertility Risk Assessment Related Terms

IVF vs RMSL, ADMT, USAQ: Risk Assessment Comparison

For the Medical Devices subindustry, INVO Fertility's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

INVO Fertility Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, INVO Fertility's Risk Assessment distribution charts can be found below:

* The bar in red indicates where INVO Fertility's Risk Assessment falls into.


IVF
35GF Score
INVO Fertility Inc IVF
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is INVO Fertility (IVF) Overvalued in 2026?

Based on GuruFocus' analysis, INVO Fertility stock appears to be undervalued. The current stock price of $1.13 is trading 99.2% below its estimated GF Value™ of $134.71. GuruFocus considers INVO Fertility to be Possible Value Trap.

Key valuation signals for IVF:

  • Risk Assessment:
  • GF Value™: $134.71 vs. price of $1.13 (99.2% below fair value)
  • GF Score™: 35/100 with 4 warning signs

No single metric tells the full story. See the IVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

INVO Fertility Business Description

Address 5582 Broadcast Court, Sarasota, FL, USA, 34240
INVO Fertility Inc is a healthcare services fertility company dedicated to expanding assisted reproductive technology (ART) care to patients in need. It is offering the intravaginal culture (IVC) procedure enabled by INVOcell medical device (INVOcell). The INVOcell is a proprietary and revolutionary medical device, and the first to allow fertilization and early embryo development to take place in vivo within the woman's body. The company's segments include: The Clinics Services operating segment consisting of financial information for WFI and the Atlanta Clinic and The INVOcell Device operating segment consisting of financial information relating to the manufacture and sales of the INVOcell.
35GF Score

Get the complete analysis for IVF

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.13
Price
$134.71
GF Value